Medicine and Dentistry
Malignant Neoplasm
81%
Hematopoietic Stem Cell Transplantation
68%
Prognostic Factor
59%
Overall Survival
59%
Non-Hodgkin Lymphoma
53%
Bone Marrow Transplantation
52%
Disease
52%
Chronic Myelogenous Leukemia
47%
Hazard Ratio
45%
Allogeneic Hematopoietic Stem Cell Transplantation
43%
Acute Myeloid Leukemia
42%
Transplantation
40%
Diffuse Large B-Cell Lymphoma
39%
Graft Versus Host Reaction
39%
Allogenic Bone Marrow Transplantation
39%
Multiple Myeloma
36%
Neoplasm
35%
Chronic Graft Versus Host Disease
34%
Multivariate Analysis
32%
Rituximab
31%
Infection
30%
Standardized Incidence Ratio
30%
Metastatic Carcinoma
26%
Myelodysplastic Syndrome
26%
Anemia
25%
Primary Tumor
25%
Symptom
23%
Carcinoembryonic Antigen
23%
Aplastic Anemia
22%
Elderly Patient
22%
Hemophagocytic Syndrome
22%
Radiation Therapy
21%
Hematologic Malignancy
21%
Leukemia
21%
Clinical Feature
20%
Proportional Hazards Model
20%
Hepatitis B
19%
Cancer
19%
NK T Cell Lymphoma
19%
Lactate Dehydrogenase
19%
Lymphocyte
19%
Doxorubicin
18%
Acute Graft Versus Host Disease
18%
Cyclophosphamide
17%
Prevalence
17%
Fever of Unknown Origin
17%
Acute Lymphoblastic Leukemia
17%
Univariate Analysis
16%
Vincristine
16%
Colorectal Cancer
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemotherapy
100%
Malignant Neoplasm
89%
Disease
66%
Fluorouracil
63%
Folinic Acid
61%
Nonhodgkin Lymphoma
52%
Metastatic Colorectal Cancer
48%
Overall Survival
47%
Rituximab
45%
Menadione
43%
Diffuse Large B Cell Lymphoma
37%
Multiple Myeloma
37%
Infection
33%
Myelodysplastic Syndrome
32%
Neoplasm
32%
Carcinoembryonic Antigen
30%
Colorectal Cancer
30%
Graft Versus Host Reaction
29%
Hematologic Malignancy
27%
Standardized Incidence Ratio
27%
Hepatitis B
27%
Stomach Cancer
26%
Oxaliplatin
26%
Colorectal Carcinoma
26%
Remission
25%
Leukemia
24%
Acute Myeloid Leukemia
22%
Progression Free Survival
22%
Hepatitis B Virus
22%
Prevalence
21%
Doxorubicin
21%
Anemia
21%
Acute Leukemia
18%
Hematologic Disease
17%
Phase II Trials
17%
Pharmacokinetics
16%
Side Effect
16%
Paclitaxel
16%
Glycoprotein
16%
Lamivudine
16%
Second Cancer
16%
Metastatic Breast Cancer
16%
Transitional Cell Carcinoma
16%
Cohort Study
16%
Breast Cancer
15%
Cyclophosphamide
15%
Cisplatin
14%
Adverse Event
14%
Clinical Feature
14%
Glutathione
13%
Immunology and Microbiology
Transplant Procedure
64%
Allogeneic Hematopoietic Stem Cell Transplantation
63%
Hematopoietic Stem Cell Transplantation
60%
B Cell
57%
Hepatitis B Virus
52%
Rituximab
52%
Bone Marrow Transplantation
47%
Graft-Versus-Host Disease
41%
Hepatitis B
38%
Multiple Myeloma
38%
Allogeneic Bone Marrow Transplantation
37%
Overall Survival
37%
Chronic Graft Versus Host Disease
33%
Hematopoietic Stem Cell
23%
Myeloid
22%
Aplastic Anemia
22%
CD34
22%
Lymphocyte Count
21%
Virus Reactivation
19%
Conditioning
18%
Hemophagocytic Lymphohistiocytosis
17%
Prevalence
17%
Cell Line
16%
Peripheral Blood Stem Cell
16%
Seroconversion
14%
Membrane Antigen
13%
Lung Function
12%
Methotrexate
12%
Fever of Unknown Origin
12%
Acute Graft Versus Host Disease
11%
Cell Migration
11%
Engraftment
11%
Ciclosporin
10%
Sialic Acid Binding Immunoglobulin Like Lectin
10%
Blood Flow
10%
Glycoprotein
10%
Leukemia Cell
10%
DNA Polymorphism
10%
Interleukin 6
10%
Idiopathic Thrombocytopenic Purpura
10%
Arm
10%
Thalidomide
10%
Mortality Rate
10%
Cyclophosphamide
10%
Stem Cell Transplantation
9%
Chimera
9%
Hepatitis B Antigen
9%
HBsAg
9%
Prednisolone
9%
Hepatitis Virus
9%
